189 related articles for article (PubMed ID: 31118608)
1. Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy.
Zhang X; Men K; Zhang Y; Zhang R; Yang L; Duan X
Int J Nanomedicine; 2019; 14():2733-2751. PubMed ID: 31118608
[No Abstract] [Full Text] [Related]
2. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.
Zhang L; Gao X; Men K; Wang B; Zhang S; Qiu J; Huang M; Gou M; Huang N; Qian Z; Zhao X; Wei Y
Int J Nanomedicine; 2011; 6():2419-27. PubMed ID: 22072877
[TBL] [Abstract][Full Text] [Related]
3. Efficient Colorectal Cancer Gene Therapy with IL-15 mRNA Nanoformulation.
Lei S; Zhang X; Men K; Gao Y; Yang X; Wu S; Duan X; Wei Y; Tong R
Mol Pharm; 2020 Sep; 17(9):3378-3391. PubMed ID: 32787272
[TBL] [Abstract][Full Text] [Related]
4. Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.
Luo L; Du T; Zhang J; Zhao W; Cheng H; Yang Y; Wu Y; Wang C; Men K; Gou M
Int J Nanomedicine; 2016; 11():501-12. PubMed ID: 26893558
[TBL] [Abstract][Full Text] [Related]
5. Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG-PCL micelles.
Duan X; Wang P; Men K; Gao X; Huang M; Gou M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Apr; 4(7):2400-7. PubMed ID: 22388488
[TBL] [Abstract][Full Text] [Related]
6. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
[TBL] [Abstract][Full Text] [Related]
7. [Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].
Pan L; Peng XC; Yuan QZ; Leng F; Yu DD; Shan Y; Li ZY; Wang CT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):390-3. PubMed ID: 20629305
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembled Nanoparticle Mediated
Xiao Y; Wang C; Xiong M; Yang Y; Zhang Q; Liu X; Zou B; Gou M
J Biomed Nanotechnol; 2018 Dec; 14(12):2092-2101. PubMed ID: 30305216
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of mSurvivinThr34→Ala in murine colon carcinoma when administered intravenously.
Li HX; Zhao XY; Wang L; Wang YS; Kan B; Xu JR; Li J; Wen YJ; Peng XC; Chen X; Yan F; Ye B; Du XB; Zhao JM; Yi T; Chen XC; Du XX; Wei YQ; Zhao X
Med Oncol; 2010 Dec; 27(4):1156-63. PubMed ID: 19949901
[TBL] [Abstract][Full Text] [Related]
10. Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene Therapy.
Zhang R; Men K; Zhang X; Huang R; Tian Y; Zhou B; Yu C; Wang Y; Ji X; Hu Q; Yang L
J Biomed Nanotechnol; 2018 Jul; 14(7):1239-1251. PubMed ID: 29944098
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.
Tu SP; Cui JT; Liston P; Huajiang X; Xu R; Lin MC; Zhu YB; Zou B; Ng SS; Jiang SH; Xia HH; Wong WM; Chan AO; Yuen MF; Lam SK; Kung HF; Wong BC
Gastroenterology; 2005 Feb; 128(2):361-75. PubMed ID: 15685548
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.
Xue Z; Sun PH; Zhu LM; Jiang SH; Qiao MM; Chi AL; Tu SP
Oncol Rep; 2011 Apr; 25(4):1039-46. PubMed ID: 21279308
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli.
Tsai SL; Chang YC; Sarvagalla S; Wang S; Coumar MS; Cheung CHA
Protein Expr Purif; 2019 Aug; 160():73-83. PubMed ID: 31004782
[TBL] [Abstract][Full Text] [Related]
15. Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient Cancer Immunogene Therapy.
Li J; Men K; Gao Y; Wu J; Lei S; Yang Y; Pan H
Mol Pharm; 2021 Nov; 18(11):4029-4045. PubMed ID: 34559545
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
[TBL] [Abstract][Full Text] [Related]
17. Cancer gene therapy using a survivin mutant adenovirus.
Mesri M; Wall NR; Li J; Kim RW; Altieri DC
J Clin Invest; 2001 Oct; 108(7):981-90. PubMed ID: 11581299
[TBL] [Abstract][Full Text] [Related]
18. [Influence of human epithelial ovarian cancer HO-8910 cells with modified survivin gene on the cell cycle distribution and chemosensitivity].
Peng LP; Huang JM; Zhang GN; Zha X; Ren Y; Fan Y; Deng BF
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):860-4. PubMed ID: 21211287
[TBL] [Abstract][Full Text] [Related]
19. Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy.
Gao Y; Men K; Pan C; Li J; Wu J; Chen X; Lei S; Gao X; Duan X
Int J Nanomedicine; 2021; 16():5211-5232. PubMed ID: 34366664
[TBL] [Abstract][Full Text] [Related]
20. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors.
Lu D; Benjamin R; Kim M; Conry RM; Curiel DT
Cancer Gene Ther; 1994 Dec; 1(4):245-52. PubMed ID: 7627814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
